RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19
NCT ID: NCT04397666
Last Updated: 2021-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
68 participants
INTERVENTIONAL
2020-05-15
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
NCT04418206
Detection of COVID-19 in Saliva Collection
NCT04386551
SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19
NCT04979871
COVID Infection in Pediatric Surgical Patient
NCT05898529
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution
NCT04664023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
conjunctival RT PCR
conjunctival sample in covid-19 patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
conjunctival RT PCR
conjunctival sample in covid-19 patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Persons over 18 years of age
* patients of both sexes
* Member of a social security scheme
* Having signed the consent form
Exclusion Criteria
* Participation in intervention research on Covid-19 involving experimental treatment
* History of chronic disease conjunctiva
* Patient with one of the one of the criteria of following gravity:
1. EN \> or =30/min,
2. Pao2/Fio2 = or \< 300,
3. confusion and/or disorientation,
4. hypotension (Tas90mmhg, requiring aggressive filling),
5. need for a invasive ventilation,
6. septic shock
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Versailles Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edouard KOCH
coordonator investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de versailles
Le Chesnay, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P20/09_COVEYES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.